About the Alberta Diabetes Institute

The Alberta Diabetes Institute is a research facility on the University of Alberta campus dedicated to translating discovery science into health solutions for the prevention, treatment and cure of diabetes. The 200,000 square foot Institute was established in 2007 as a stand-alone facility to consolidate the University’s outstanding collection of diabetes researchers and their trainees. The Institute offers state-of-the-art facilities in support of research that includes cellular and molecular studies, preclinical/clinical research, population health and health outcomes studies. 

The Alberta Diabetes Institute uses an integrated, multidisciplinary and collaborative approach towards diabetes research and health solutions. Diabetes is a disease whose onset is influenced by numerous hereditary, lifestyle, environmental and even social factors. An effective approach to understanding and ultimately curing diabetes, whether it be Type 1, Type 2 or gestational, can only be achieved by integrating the knowledge from disciplines that are diverse in scope and focus. The Institute brings together some of the world’s leading diabetes researchers from disciplines that range from cell biology to nutrition/metabolism to aboriginal health, and provides an environment where their research is integrated into practical applications in the following areas:

Research Areas at ADI


The Alberta Diabetes Institute continues to build on its past success with a team dedicated to overcoming diabetes. The University of Alberta has a celebrated history in diabetes that extends back to Dr. James Collip’s contributions towards the purification and first clinical use of insulin in 1922 to the internationally acclaimed Edmonton Protocol, the world’s gold-standard for transplanting islet cells in Type 1 diabetes patients and relieving them of daily insulin injections.

The Alberta Diabetes Institute now boasts 60 scientists that are leading experts in their fields. This group has generated thousands of significant peer-reviewed journal articles related to diabetes that reflect ongoing progress towards understanding and treating all forms of diabetes. Strength of publications, as measured by journal citation metrics like h-indices, are amongst the highest in the world and rising. In 2013 members held over $90 million in grant funding, and the Institute takes full advantage of the significant investment that has been made to promote translational health research in Alberta.